Lornoxicam

Lornoxicam is a potent non-steroidal anti-inflammatory drug (NSAID) belonging to the oxicam class, commonly used for the short-term management of pain and inflammation associated with musculoskeletal conditions. It is frequently prescribed in acute back pain, postoperative pain, dental pain, and flare-ups of osteoarthritis or rheumatoid arthritis where rapid symptom relief is required.

The medication works by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, which play a central role in the production of prostaglandins—chemical mediators responsible for pain, swelling, and inflammation. By reducing prostaglandin synthesis, lornoxicam helps decrease tissue inflammation, improve mobility, and provide effective analgesia. Its relatively quick onset of action makes it particularly useful in acute painful conditions where prompt relief is desired.

Clinically, lornoxicam is valued for its balanced anti-inflammatory and analgesic profile. It is usually prescribed for short durations to minimize the gastrointestinal and cardiovascular risks associated with long-term NSAID use. Patients are typically advised to take the medicine after food to reduce stomach irritation. In individuals with a history of peptic ulcer disease, kidney impairment, or cardiovascular risk factors, careful medical supervision is recommended.

While effective, lornoxicam should be used at the lowest effective dose for the shortest necessary duration. Patients should avoid combining it with other NSAIDs unless specifically directed by a healthcare provider. With appropriate use and monitoring, lornoxicam remains a useful option for managing acute inflammatory pain in orthopedic and general clinical practice.